The Pharmacy Times® Hepatitis resource center provides clinical news and articles, pertaining to the Food and Drug Administration approved therapies to treat Hepatitis A, B, and C. Additionally, pharmacists will find coverage from pertinent conferences and meetings, videos, podcasts, and other associated content.
An increasing number of patients with decompensated cirrhosis are receiving direct-acting antiviral treatment and attaining sustained virologic response of hepatitis C, however, their long-term outcomes are unclear.
New research supports the use of direct-acting antiviral therapy for all individuals with chronic hepatitis C infection.
The Pharmacy Times® Hepatitis condition center provides a source of all the latest clinical information, with articles covering updates from the robust pipeline of novel diabetes therapies, and the newest data from all phases of clinical trials and studies in the space.
Among its other resources are a wealth of videos including interviews with thought leaders and experts in the inflammatory liver disease, and moderated Peer Exchange panels featuring the world’s leading hepatologists and gastroenterologists discussing best practices and key methods for treating complex cases, utilizing the newest therapies, examining the issues and challenges of treating the disease, and much more.